News

Filter

Current filters:

sirolimus

1 to 9 of 76 results

Santen's first-half income plummets 46%

08-12-2008

Santen Pharmaceuticals, a Japanese drugmaker, reported a severe fall in profit for the six months ending…

Rapamunesirolimus

Japan stock market week to June 9, 2008

16-06-2008

Tokyo retreated in the week ended June 9 due to profit-taking on select stocks. The Nikkei 225 fell 1.8%,…

Daiichi SankyoGlaxoSmithKlineGSKHumulin 70-30Humulin NHumulin RInsulinNystatinOralRapamuneSankyosirolimus

Everolimus trial halted after early PFS gains

10-03-2008

Swiss drug major Novartis says that a late-stage Phase III trial of its kidney cancer drug everolimus…

AspirinAvastinBayerBayerbevacizumabNexavarNovartisPfizerRapamuneRochesirolimusSorafenibSunitinib MalateSutentTemsirolimus InjectionToriselWyeth

Sirolimus impresses in Ph I wet AMD trial

03-03-2008

MacuSight, a USA-based developer of therapeutics for the treatment of severe ocular conditions, says…

Amino AcidsInjectionPhysostigmine SalicylateRapamunesirolimus

Cypher fares well vs bare metal stents

10-09-2007

The Cypher sirolimus-eluting coronary stent continued to provide clinical benefits compared to a bare…

Johnson & JohnsonRapamunesirolimus

1 to 9 of 76 results

COMPANY SPOTLIGHT

Menarini

Back to top